Medtronic saw $8.3 billion in revenue during the third quarter of fiscal year 2025, according to financial results posted Feb. 18.
Spinal Tech
From leadership changes to new deals, here's what Stryker has done so far in 2025.
Here are five headlines to know about Medtronic, as reported by Becker's since Jan. 7:
From financial results to new acquisitions, here are seven key updates from spine and orthopedic devicemakers since Feb. 5.
Stryker sold its U.S. spinal implants to the Viscogliosi Brothers, and market analysts with GlobalData predict the move will benefit competitors in spinal fusion, according to a Feb. 12 news release.
Medtronic acquired rights and intellectual property related to Nanovis' Sites Medical's OsteoSync titanium pads, according to a Feb. 12 news release.
Palm Beach Gardens, Fla.-based spinal implant medical technology company Accelus has received regulatory approval in Brazil for its FlareHawk Interbody Fusion System.
More than 10,000 procedures using Centinel Spine's prodisc cervical total disc replacement system have been completed, the company said Feb. 11.
Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth-quarter financial results for 2024 and data on their spine orthopedic sales.
Globus Medical is acquiring Nevro Corp, a spinal cord stimulator company, according to a Feb. 6 news release.